Affiliated Cancer Hospital of Xinjiang Medical University — Ürümqi

Public research footprint of Affiliated Cancer Hospital of Xinjiang Medical University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Chronic Lymphocytic Leukemia · Mantle Cell Lymphoma; Non-Hodgkin Lymphoma · HER2-positive Breast Cancer

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06191744 — Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Affiliated Cancer Hospital of Xinjiang Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.